Comparasion of Midazolam, Lorazepam and Haloperidol-Promethazine combination for management of physically and verbally violent patients.
Phase 4
- Conditions
- Health Condition 1: F40-F48- Anxiety, dissociative, stress-related, somatoform and other nonpsychotic mental disordersHealth Condition 2: F10-F19- Mental and behavioral disorders due to psychoactive substance useHealth Condition 3: F30-F39- Mood [affective] disordersHealth Condition 4: F20-F29- Schizophrenia, schizotypal, delusional, and other non-mood psychotic disorders
- Registration Number
- CTRI/2024/07/070438
- Lead Sponsor
- Government Medical College and Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Altered Mental Status Scale (AMSS) score greater than 1
Exclusion Criteria
Patient with known allergy of either midazolam or lorazepam or haloperidol or
promethazine.
Patient with medically reversible cause of agitation (hypotension, hypoxia or
hypoglycemia).
Patient known to be pregnant or lactating.
Patient presenting with drug withdrawals or drug intoxication within past 48 hours.
Patient with history of head injury within past 48 hours.
Patient in active Delirium.
Patient chemically restrained in past 24 hours.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method